Top Markets
Coin of the day
InDex Pharmaceuticals Holding AB (publ) InDex Pharmaceuticals Holding AB (publ)

InDex Pharmaceuticals Holding AB (publ)

INDEX
Rank in Stocks #28996
InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to... InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to developing therapeutic solutions for patients affected by ulcerative colitis. The company's flagship drug candidate, Cobitolimod, is presently in Phase III clinical trials, targeting the treatment of moderate to severe ulcerative colitis. Furthermore, InDex is progressing a pipeline of other DNA-based immunomodulatory sequences, which are in the preclinical phase, designed to address various immunological conditions. This enterprise was established in 2000 and operates from its headquarters in Solna, Sweden.
Share Price
$0.04406501
Last synced: 2024-07-09
Market Cap
$23.47M
Change (1 day)
-0.48%
Change (1 year)
0.00%
Country
SE
Trade InDex Pharmaceuticals Holding AB (publ) (INDEX)

Category

Stock price history for InDex Pharmaceuticals Holding AB (publ) (INDEX)
Highest end of day price: $0.04 on 2024-07-01

Lowest end of day price: $0.27 on 2016-10-01
Stock price history of InDex Pharmaceuticals Holding AB (publ) from 2016 to 2026
Annual Stock Price Performance
Year Performance
2024 87.14%
2023 -26.23%
2022 -50.30%
2021 -15.30%
2020 -67.25%
2019 -14.75%
2018 30.01%
2017 -11.67%
2016 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$552.07 41.28%
US
$168.77 504.69%
US
$1.03K 57.19%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH